Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Apr;78(4):252–259. doi: 10.1136/bjo.78.4.252

Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.

A D Paridaens 1, D C Minassian 1, A C McCartney 1, J L Hungerford 1
PMCID: PMC504757  PMID: 8199108

Abstract

A series of 256 consecutive cases of invasive primary conjunctival malignant melanomas was examined to identify clinical and histopathological prognostic factors. The follow up period varied between 0.3 and 45.9 years (mean 9 years, median 6.3 years). The 5 year survival rate was estimated at 82.9%, the 10 year survival rate at 69.3%. Multiple regression analysis with the Cox proportional hazards model was used to assess sex, age, and a number of baseline features of conjunctival malignant melanoma as possible prognostic factors influencing melanoma related mortality. In assessing each potential prognostic factor, the effects of all other factors were taken into account in the modelling process. Tumours in unfavourable locations--that is, those involving the palpebral conjunctiva, fornices, plica, caruncle, and lid margins, were associated with 2.2 times higher mortality compared with (epi)bulbar melanomas. Patients with mixed cell type tumours had about three times higher mortality compared with those with pure spindle cell melanomas, and histological evidence of lymphatic invasion by tumour cells was also a prognostic feature, carrying a fourfold increase in the death rate. Multifocal tumours were associated with a fivefold increase in mortality among those with tumours in favourable (epi)bulbar locations, but were not prognostic in patients with melanomas in unfavourable sites. The death rate was significantly higher in those with initial tumour thickness of more than 4 mm, but only among patients with unfavourably located melanomas. Sex, age, and clinical origin of the tumour (primary acquired melanosis, pre-existing naevus, or de novo) were not useful prognostic indicators in this study.

Full text

PDF
255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASH J. E. Epibulbar tumors. Am J Ophthalmol. 1950 Aug;33(8):1203–1219. doi: 10.1016/0002-9394(50)90990-1. [DOI] [PubMed] [Google Scholar]
  2. Bernardino V. B., Naidoff M. A., Clark W. H. Malignant melanomas of the conjunctiva. Am J Ophthalmol. 1976 Sep;82(3):383–394. doi: 10.1016/0002-9394(76)90487-6. [DOI] [PubMed] [Google Scholar]
  3. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902–908. doi: 10.1097/00000658-197011000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Char D. H. The management of lid and conjunctival malignancies. Surv Ophthalmol. 1980 May-Jun;24(6):679–689. doi: 10.1016/0039-6257(80)90127-7. [DOI] [PubMed] [Google Scholar]
  5. Conley J., Pack G. T. Melanoma of the mucous membranes of the head and neck. Arch Otolaryngol. 1974 May;99(5):315–319. doi: 10.1001/archotol.1974.00780030327001. [DOI] [PubMed] [Google Scholar]
  6. Crawford J. B. Conjunctival melanomas: prognostic factors a review and an analysis of a series. Trans Am Ophthalmol Soc. 1980;78:467–502. [PMC free article] [PubMed] [Google Scholar]
  7. Folberg R., McLean I. W., Zimmerman L. E. Malignant melanoma of the conjunctiva. Hum Pathol. 1985 Feb;16(2):136–143. doi: 10.1016/s0046-8177(85)80062-9. [DOI] [PubMed] [Google Scholar]
  8. Fuchs U., Kivelä T., Liesto K., Tarkkanen A. Prognosis of conjunctival melanomas in relation to histopathological features. Br J Cancer. 1989 Feb;59(2):261–267. doi: 10.1038/bjc.1989.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Grove A. S., Jr Melanomas of the conjunctiva. Int Ophthalmol Clin. 1980 Summer;20(2):161–175. [PubMed] [Google Scholar]
  10. JAY B. NAEVI AND MELANOMATA OF THE CONJUNCTIVA. Br J Ophthalmol. 1965 Apr;49:169–204. doi: 10.1136/bjo.49.4.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jakobiec F. A. Conjunctival melanoma. Arch Ophthalmol. 1980 Aug;98(8):1378–1384. doi: 10.1001/archopht.1980.01020040230003. [DOI] [PubMed] [Google Scholar]
  12. Jakobiec F. A., Rini F. J., Fraunfelder F. T., Brownstein S. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases. Ophthalmology. 1988 Aug;95(8):1058–1070. doi: 10.1016/s0161-6420(88)33058-7. [DOI] [PubMed] [Google Scholar]
  13. Jeffrey I. J., Lucas D. R., McEwan C., Lee W. R. Malignant melanoma of the conjunctiva. Histopathology. 1986 Apr;10(4):363–378. doi: 10.1111/j.1365-2559.1986.tb02490.x. [DOI] [PubMed] [Google Scholar]
  14. Liesegang T. J., Campbell R. J. Mayo Clinic experience with conjunctival melanomas. Arch Ophthalmol. 1980 Aug;98(8):1385–1389. doi: 10.1001/archopht.1980.01020040237004. [DOI] [PubMed] [Google Scholar]
  15. Lommatzsch P. K., Lommatzsch R. E., Kirsch I., Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol. 1990 Oct;74(10):615–619. doi: 10.1136/bjo.74.10.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lund V. Malignant melanoma of the nasal cavity and paranasal sinuses. J Laryngol Otol. 1982 Apr;96(4):347–355. doi: 10.1017/s0022215100092586. [DOI] [PubMed] [Google Scholar]
  17. McGovern V. J., Shaw H. M., Milton G. W., Farago G. A. Prognostic significance of the histological features of malignant melanoma. Histopathology. 1979 Sep;3(5):385–393. doi: 10.1111/j.1365-2559.1979.tb03020.x. [DOI] [PubMed] [Google Scholar]
  18. Paridaens A. D., Kirkness C. M., Garner A., Hungerford J. L. Recurrent malignant melanoma of the corneal stroma: a case of 'black cornea'. Br J Ophthalmol. 1992 Jul;76(7):444–446. doi: 10.1136/bjo.76.7.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Paridaens A. D., McCartney A. C., Hungerford J. L. Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento. Br J Ophthalmol. 1992 Mar;76(3):163–165. doi: 10.1136/bjo.76.3.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Paridaens A. D., McCartney A. C., Lavelle R. J., Hungerford J. L. Nasal and orbital recurrence of conjunctival melanoma 21 years after exenteration. Br J Ophthalmol. 1992 Jun;76(6):369–371. doi: 10.1136/bjo.76.6.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Paridaens A. D., Seregard S., Minassian D., Hungerford J. L., McCartney A. C. AgNOR counts in conjunctival malignant melanoma lack prognostic value. Br J Ophthalmol. 1992 Oct;76(10):621–623. doi: 10.1136/bjo.76.10.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Paridaens D. A., Alexander R. A., Hungerford J. L., McCartney A. C. Oestrogen receptors in conjunctival malignant melanoma: immunocytochemical study using formalin fixed paraffin wax sections. J Clin Pathol. 1991 Oct;44(10):840–843. doi: 10.1136/jcp.44.10.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Robertson D. M., Hungerford J. L., McCartney A. Malignant melanomas of the conjunctiva, nasal cavity, and paranasal sinuses. Am J Ophthalmol. 1989 Oct 15;108(4):440–442. doi: 10.1016/s0002-9394(14)73314-8. [DOI] [PubMed] [Google Scholar]
  24. Robertson D. M., Hungerford J. L., McCartney A. Pigmentation of the eyelid margin accompanying conjunctival melanoma. Am J Ophthalmol. 1989 Oct 15;108(4):435–439. doi: 10.1016/s0002-9394(14)73313-6. [DOI] [PubMed] [Google Scholar]
  25. Stefani F. H. A prognostic index for patients with malignant melanoma of the conjunctiva. Graefes Arch Clin Exp Ophthalmol. 1986;224(6):580–582. doi: 10.1007/BF02154748. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES